|
1
|
Breslow N, Olshan A, Beckwith JB and Green
DM: Epidemiology of Wilms tumor. Med Pediatr Oncol. 21:172–181.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brok J, Treger TD, Gooskens SL, van den
Heuvel-Eibrink MM and Pritchard-Jones K: Biology and treatment of
renal tumours in childhood. Eur J Cancer. 68:179–195. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chu A, Heck JE, Ribeiro KB, Brennan P,
Boffetta P, Buffler P and Hung RJ: Wilms' tumour: A systematic
review of risk factors and meta-analysis. Paediatr Perinat
Epidemiol. 24:449–469. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pastore G, Znaor A, Spreafico F, Graf N,
Pritchard-Jones K and Steliarova-Foucher E: Malignant renal tumours
incidence and survival in European children (1978–1997): Report
from the Automated Childhood Cancer Information System project. Eur
J Cancer. 42:2103–2114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Magnani C, Pastore G, Coebergh JW, Viscomi
S, Spix C and Steliarova-Foucher E: Trends in survival after
childhood cancer in Europe, 1978-1997: Report from the Automated
Childhood Cancer Information System project (ACCIS). Eur J Cancer.
42:1981–2005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geller JI: Current standards of care and
future directions for ‘high-risk’ pediatric renal tumors:
Anaplastic Wilms tumor and Rhabdoid tumor. Urol Oncol. 34:50–56.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spreafico F, Pritchard Jones K,
Malogolowkin MH, Bergeron C, Hale J, de Kraker J, Dallorso S, Acha
T, de Camargo B, Dome JS, et al: Treatment of relapsed Wilms
tumors: Lessons learned. Expert Rev Anticancer Ther. 9:1807–1815.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu S, Fu W, Zhang L, Fu K, Hu J, Jia W
and Liu G: LINC00473 antagonizes the tumour suppressor miR-195 to
mediate the pathogenesis of Wilms tumour via IKKα. Cell Prolif. Nov
20–2017.(Epub ahead of print). doi:
https://doi.org/10.1111/cpr.12416.
|
|
9
|
Yu X, Li Z, Chan MT and Wu WK: The roles
of microRNAs in Wilms' tumors. Tumour Biol. 37:1445–1450. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su L, Wu A, Zhang W and Kong X: Silencing
long non-coding RNA SNHG6 restrains proliferation, migration and
invasion of Wilms' tumour cell lines by regulating miR-15a. Artif
Cells Nanomed Biotechnol. 47:2670–2677. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Muers M: RNA: Genome-wide views of long
non-coding RNAs. Nat Rev Genet. 12:742–743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye W, Lv Q, Wong CK, Hu S, Fu C, Hua Z,
Cai G, Li G, Yang BB and Zhang Y: The effect of central loops in
miRNA:MRE duplexes on the efficiency of miRNA-mediated gene
regulation. PLoS One. 3:e17192008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cao X, Liu D, Yan X, Zhang Y, Yuan L,
Zhang T, Fu M, Zhou Y and Wang J: Stat3 inhibits WTX expression
through up-regulation of microRNA-370 in Wilms tumor. FEBS Lett.
587:639–644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang X and Li H: MiR-1180-5p regulates
apoptosis of Wilms' tumor by targeting p73. OncoTargets Ther.
11:823–831. 2018. View Article : Google Scholar
|
|
16
|
Cui M, Liu W, Zhang L, Guo F, Liu Y, Chen
F, Liu T, Ma R and Wu R: Over-expression of miR-21 and lower PTEN
levels in Wilms' tumor with aggressive behavior. Tohoku J Exp Med.
242:43–52. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu GL, Yang HJ, Liu B and Liu T: Effects
of MicroRNA-19b on the proliferation, apoptosis, and migration of
Wilms' tumor cells via the PTEN/PI3K/AKT signaling pathway. J Cell
Biochem. 118:3424–3434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okamoto K, Morison IM, Taniguchi T and
Reeve AE: Epigenetic changes at the insulin-like growth factor
II/H19 locus in developing kidney is an early event in Wilms
tumorigenesis. Proc Natl Acad Sci USA. 94:5367–5371. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Hou T, Qi X, Wang J and Sun X:
SOX21-AS1 is associated with clinical stage and regulates cell
proliferation in nephroblastoma. Biosci Rep. May 17–2019.(Epub
ahead of print). doi: 10.1042/BSR20190602.
|
|
20
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther. 1:150042016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su H, Wang X, Song J, Wang Y, Zhao Y and
Meng J: MicroRNA-539 inhibits the progression of Wilms' tumor
through downregulation of JAG1 and Notch1/3. Cancer Biomark.
24:125–133. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu H, Zhang Z, Wu N, Guo H, Zhang H, Fan
D, Nie Y and Liu Y: Integrative analysis of dysregulated
lncRNA-associated ceRNA network reveals functional lncRNAs in
gastric cancer. Genes (Basel). Jun 18–2018.(Epub ahead of print).
doi: 10.3390/genes9060303.
|
|
24
|
Arun K, Arunkumar G, Bennet D,
Chandramohan SM, Murugan AK and Munirajan AK: Comprehensive
analysis of aberrantly expressed lncRNAs and construction of ceRNA
network in gastric cancer. Oncotarget. 9:18386–18399. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao C, Li H, Zhuang J, Zhang H, Wang K,
Yang J, Liu C, Liu L, Zhou C and Sun C: The construction and
analysis of ceRNA networks in invasive breast cancer: A study based
on The Cancer Genome Atlas. Cancer Manag Res. 11:1–11. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yan Y, Yu J, Liu H, Guo S, Zhang Y, Ye Y,
Xu L and Ming L: Construction of a long non-coding RNA-associated
ceRNA network reveals potential prognostic lncRNA biomarkers in
hepatocellular carcinoma. Pathol Res Pract. 214:2031–2038. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan W, Li X, Liu L, Wei C, Sun D, Peng S
and Jiang L: Comprehensive analysis of lncRNA-associated ceRNA
network in colorectal cancer. Biochem Biophys Res Commun.
508:374–379. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Weinstein JN, Collisson EA, Mills GB, Shaw
KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C and Stuart JM;
Cancer Genome Atlas Research Network, : The Cancer Genome Atlas
Pan-Cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aken BL, Ayling S, Barrell D, Clarke L,
Curwen V, Fairley S, Fernandez Banet J, Billis K, García Girón C,
Hourlier T, et al: The Ensembl gene annotation system. Database
(Oxford). Jun 23–2016.(Epub ahead of print). doi:
10.1093/database/baw093. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jeggari A, Marks DS and Larsson E:
miRcode: A map of putative microRNA target sites in the long
non-coding transcriptome. Bioinformatics. 28:2062–2063. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43:D146–D152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsu SD, Lin FM, Wu WY, Liang C, Huang WC,
Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, et al: miRTarBase: A
database curates experimentally validated microRNA-target
interactions. Nucleic Acids Res. 39 (Suppl 1):D163–D169. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Blake JA and Harris MA: The Gene Ontology
(GO) project: Structured vocabularies for molecular biology and
their application to genome and expression analysis. Curr Protoc
Bioinformatics. Sep 1–2008.(Epub ahead of print). doi:
https://doi.org/10.1002/0471250953.bi0702s23. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bland JM and Altman DG: The logrank test.
BMJ. 328:10732004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ludwig N, Werner TV, Backes C, Trampert P,
Gessler M, Keller A, Lenhof HP, Graf N and Meese E: Combining miRNA
and mRNA Expression Profiles in Wilms Tumor Subtypes. Int J Mol
Sci. 17:4752016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu M, Roth A, Yu M, Morris R, Bersani F,
Rivera MN, Lu J, Shioda T, Vasudevan S, Ramaswamy S, et al: The
IGF2 intronic miR-483 selectively enhances transcription from IGF2
fetal promoters and enhances tumorigenesis. Genes Dev.
27:2543–2548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Barabási AL and Oltvai ZN: Network
biology: Understanding the cell's functional organization. Nat Rev
Genet. 5:101–113. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tian F, Yourek G, Shi X and Yang Y: The
development of Wilms tumor: From WT1 and microRNA to animal models.
Biochim Biophys Acta. 1846:180–187. 2014.PubMed/NCBI
|
|
45
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chan JJ and Tay Y: Noncoding RNA:RNA
Regulatory Networks in Cancer. Int J Mol Sci. 19:E13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Klein U, Lia M, Crespo M, Siegel R, Shen
Q, Mo T, Ambesi-Impiombato A, Califano A, Migliazza A, Bhagat G, et
al: The DLEU2/miR-15a/16-1 cluster controls B cell proliferation
and its deletion leads to chronic lymphocytic leukemia. Cancer
Cell. 17:28–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lerner M, Harada M, Lovén J, Castro J,
Davis Z, Oscier D, Henriksson M, Sangfelt O, Grandér D and Corcoran
MM: DLEU2, frequently deleted in malignancy, functions as a
critical host gene of the cell cycle inhibitory microRNAs miR-15a
and miR-16-1. Exp Cell Res. 315:2941–2952. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xie ZZ, Xiao ZC, Song YX, Li W and Tan GL:
Long non-coding RNA Dleu2 affects proliferation, migration and
invasion ability of laryngeal carcinoma cells through triggering
miR-16-1 pathway. Eur Rev Med Pharmacol Sci. 22:1963–1970.
2018.PubMed/NCBI
|
|
51
|
Tan W, Liu B, Qu S, Liang G, Luo W and
Gong C: MicroRNAs and cancer: Key paradigms in molecular therapy.
Oncol Lett. 15:2735–2742. 2018.PubMed/NCBI
|
|
52
|
Ludwig N, Nourkami-Tutdibi N, Backes C,
Lenhof HP, Graf N, Keller A and Meese E: Circulating serum miRNAs
as potential biomarkers for nephroblastoma. Pediatr Blood Cancer.
62:1360–1367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mokutani Y, Uemura M, Munakata K, Okuzaki
D, Haraguchi N, Takahashi H, Nishimura J, Hata T, Murata K,
Takemasa I, et al: Down-Regulation of microRNA-132 is Associated
with Poor Prognosis of Colorectal Cancer. Ann Surg Oncol. 23 (Suppl
5):599–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Park JK, Henry JC, Jiang J, Esau C, Gusev
Y, Lerner MR, Postier RG, Brackett DJ and Schmittgen TD: miR-132
and miR-212 are increased in pancreatic cancer and target the
retinoblastoma tumor suppressor. Biochem Biophys Res Commun.
406:518–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tian H, Hou L, Xiong YM, Huang JX, Zhang
WH, Pan YY and Song XR: miR-132 targeting E2F5 suppresses cell
proliferation, invasion, migration in ovarian cancer cells. Am J
Transl Res. 8:1492–1501. 2016.PubMed/NCBI
|
|
56
|
Zhang X, Tang W, Li R, He R, Gan T, Luo Y,
Chen G and Rong M: Downregulation of microRNA-132 indicates
progression in hepatocellular carcinoma. Exp Ther Med.
12:2095–2101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Filion GJ, Zhenilo S, Salozhin S, Yamada
D, Prokhortchouk E and Defossez PA: A family of human zinc finger
proteins that bind methylated DNA and repress transcription. Mol
Cell Biol. 26:169–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kim K, Chadalapaka G, Lee SO, Yamada D,
Sastre-Garau X, Defossez PA, Park YY, Lee JS and Safe S:
Identification of oncogenic microRNA-17-92/ZBTB4/specificity
protein axis in breast cancer. Oncogene. 31:1034–1044. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ross-Adams H, Lamb AD, Dunning MJ, Halim
S, Lindberg J, Massie CM, Egevad LA, Russell R, Ramos-Montoya A,
Vowler SL, et al CamCaP Study Group, : Integration of copy number
and transcriptomics provides risk stratification in prostate
cancer: A discovery and validation cohort study. EBioMedicine.
2:1133–1144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yu Y, Shang R, Chen Y, Li J, Liang Z, Hu
J, Liu K and Chen C: Tumor suppressive ZBTB4 inhibits cell growth
by regulating cell cycle progression and apoptosis in Ewing
sarcoma. Biomed Pharmacother. 100:108–115. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Roussel-Gervais A, Naciri I, Kirsh O,
Kasprzyk L, Velasco G, Grillo G, Dubus P and Defossez PA: Loss of
the Methyl-CpG-Binding Protein ZBTB4 Alters Mitotic Checkpoint,
Increases Aneuploidy, and Promotes Tumorigenesis. Cancer Res.
77:62–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tao F, Tian X, Ruan S, Shen M and Zhang Z:
miR-211 sponges lncRNA MALAT1 to suppress tumor growth and
progression through inhibiting PHF19 in ovarian carcinoma. FASEB J.
Jun 6–2018.(Epub ahead of print). doi: 10.1096/fj.201800495RR.
View Article : Google Scholar
|
